These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 31638560)

  • 1. Review of SRD5A3 Disease-Causing Sequence Variants and Ocular Findings in Steroid 5α-Reductase Type 3 Congenital Disorder of Glycosylation, and a Detailed New Case.
    Kousal B; Honzík T; Hansíková H; Ondrušková N; Čechová A; Tesařová M; Stránecký V; Meliška M; Michaelides M; Lišková P
    Folia Biol (Praha); 2019; 65(3):134-141. PubMed ID: 31638560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Steroid 5α-Reductase Type 3 Congenital Disorder of Glycosylation With Early-Onset Retinal Dystrophy.
    Taylor RL; Arno G; Poulter JA; Khan KN; Morarji J; Hull S; Pontikos N; Rueda Martin A; Smith KR; Ali M; Toomes C; McKibbin M; Clayton-Smith J; Grunewald S; Michaelides M; Moore AT; Hardcastle AJ; Inglehearn CF; Webster AR; Black GC;
    JAMA Ophthalmol; 2017 Apr; 135(4):339-347. PubMed ID: 28253385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult phenotype and further phenotypic variability in SRD5A3-CDG.
    Kara B; Ayhan Ö; Gökçay G; Başboğaoğlu N; Tolun A
    BMC Med Genet; 2014 Jan; 15():10. PubMed ID: 24433453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SRD5A3-CDG: a patient with a novel mutation.
    Kasapkara CS; Tümer L; Ezgü FS; Hasanoğlu A; Race V; Matthijs G; Jaeken J
    Eur J Paediatr Neurol; 2012 Sep; 16(5):554-6. PubMed ID: 22240719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SRD5A3-CDG: Expanding the phenotype of a congenital disorder of glycosylation with emphasis on adult onset features.
    Wheeler PG; Ng BG; Sanford L; Sutton VR; Bartholomew DW; Pastore MT; Bamshad MJ; Kircher M; Buckingham KJ; Nickerson DA; Shendure J; Freeze HH
    Am J Med Genet A; 2016 Dec; 170(12):3165-3171. PubMed ID: 27480077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SRD5A3-CDG: Twins with an intragenic tandem duplication.
    Rieger M; Türk M; Kraus C; Uebe S; Ekici AB; Krumbiegel M; Huchzermeyer C; Reis A; Thiel C
    Eur J Med Genet; 2022 May; 65(5):104492. PubMed ID: 35339718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SRD5A3-CDG: 3D structure modeling, clinical spectrum, and computer-based dysmorphic facial recognition.
    Ben Ayed I; Ouarda W; Frikha F; Kammoun F; Souissi A; Ben Said M; Bouzid A; Elloumi I; Hamdani TM; Gharbi N; Baklouti N; Guirat M; Mejdoub F; Kharrat N; Boujelbene I; Abdelhedi F; Belguith N; Keskes L; Gibriel AA; Kamoun H; Triki C; Alimi AM; Masmoudi S
    Am J Med Genet A; 2021 Apr; 185(4):1081-1090. PubMed ID: 33403770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel cerebello-ocular syndrome with abnormal glycosylation due to abnormalities in dolichol metabolism.
    Morava E; Wevers RA; Cantagrel V; Hoefsloot LH; Al-Gazali L; Schoots J; van Rooij A; Huijben K; van Ravenswaaij-Arts CM; Jongmans MC; Sykut-Cegielska J; Hoffmann GF; Bluemel P; Adamowicz M; van Reeuwijk J; Ng BG; Bergman JE; van Bokhoven H; Körner C; Babovic-Vuksanovic D; Willemsen MA; Gleeson JG; Lehle L; de Brouwer AP; Lefeber DJ
    Brain; 2010 Nov; 133(11):3210-20. PubMed ID: 20852264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Life with too much polyprenol: polyprenol reductase deficiency.
    Gründahl JE; Guan Z; Rust S; Reunert J; Müller B; Du Chesne I; Zerres K; Rudnik-Schöneborn S; Ortiz-Brüchle N; Häusler MG; Siedlecka J; Swiezewska E; Raetz CR; Marquardt T
    Mol Genet Metab; 2012 Apr; 105(4):642-51. PubMed ID: 22304929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-onset retinal dystrophy and chronic dermatitis in a girl with an undiagnosed congenital disorder of glycosylation (SRD5A3-CDG).
    Khan AO
    Ophthalmic Genet; 2018 Oct; 39(5):628-630. PubMed ID: 30019980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SRD5A3-CDG: A Patient with a Novel Variant and Brain Neoplasm.
    Kasapkara CS; Olgac A; Derinkuyu BE; Oztoprak U; Jaeken J
    J Coll Physicians Surg Pak; 2022 Dec; 32(12):SS221-SS226. PubMed ID: 36597345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Next generation sequencing in a family with autosomal recessive Kahrizi syndrome (OMIM 612713) reveals a homozygous frameshift mutation in SRD5A3.
    Kahrizi K; Hu CH; Garshasbi M; Abedini SS; Ghadami S; Kariminejad R; Ullmann R; Chen W; Ropers HH; Kuss AW; Najmabadi H; Tzschach A
    Eur J Hum Genet; 2011 Jan; 19(1):115-7. PubMed ID: 20700148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-glycoproteomic and proteomic alterations in SRD5A3-deficient fibroblasts.
    Garapati K; Ranatunga W; Joshi N; Budhraja R; Sabu S; Kantautas KA; Preston G; Perlstein EO; Kozicz T; Morava E; Pandey A
    Glycobiology; 2024 Sep; 34(11):. PubMed ID: 39360848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal Uniparental Isodisomy of Chromosome 4 and 8 in Patients with Retinal Dystrophy:
    Tachibana N; Hosono K; Nomura S; Arai S; Torii K; Kurata K; Sato M; Shimakawa S; Azuma N; Ogata T; Wada Y; Okamoto N; Saitsu H; Nishina S; Hotta Y
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique clinical presentations and follow-up outcomes from experience with congenital disorders of glycosylation: PMM2-PGM1-DPAGT1-MPI-POMT2-B3GALNT2-DPM1-SRD5A3-CDG.
    Yoldas Celik M; Yazici H; Erdem F; Yuksel Yanbolu A; Aykut A; Durmaz A; Zeybek S; Canda E; Kalkan Ucar S; Coker M
    J Pediatr Endocrinol Metab; 2023 Jun; 36(6):530-538. PubMed ID: 37042760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SRD5A3-CDG: Emerging Phenotypic Features of an Ultrarare CDG Subtype.
    Kamarus Jaman N; Rehsi P; Henderson RH; Löbel U; Mankad K; Grunewald S
    Front Genet; 2021; 12():737094. PubMed ID: 34925443
    [No Abstract]   [Full Text] [Related]  

  • 17. A rare case of SRD5A3-CDG in a patient with ataxia and telangiectasia: A case report.
    Nabavizadeh SH; Noeiaghdam R; Johari L; Hosseini SA; Esmaeilzadeh H; Alyasin SS
    Clin Case Rep; 2022 Nov; 10(11):e6564. PubMed ID: 36439385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Congenital disorder of glycosylation type Ij (CDG-Ij, DPAGT1-CDG): extending the clinical and molecular spectrum of a rare disease.
    Würde AE; Reunert J; Rust S; Hertzberg C; Haverkämper S; Nürnberg G; Nürnberg P; Lehle L; Rossi R; Marquardt T
    Mol Genet Metab; 2012 Apr; 105(4):634-41. PubMed ID: 22304930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SRD5A3 is required for converting polyprenol to dolichol and is mutated in a congenital glycosylation disorder.
    Cantagrel V; Lefeber DJ; Ng BG; Guan Z; Silhavy JL; Bielas SL; Lehle L; Hombauer H; Adamowicz M; Swiezewska E; De Brouwer AP; Blümel P; Sykut-Cegielska J; Houliston S; Swistun D; Ali BR; Dobyns WB; Babovic-Vuksanovic D; van Bokhoven H; Wevers RA; Raetz CR; Freeze HH; Morava E; Al-Gazali L; Gleeson JG
    Cell; 2010 Jul; 142(2):203-17. PubMed ID: 20637498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pseudoautosomal glycosylation disorder prompts the revision of dolichol biosynthesis.
    Wilson MP; Kentache T; Althoff CR; Schulz C; de Bettignies G; Mateu Cabrera G; Cimbalistiene L; Burnyte B; Yoon G; Costain G; Vuillaumier-Barrot S; Cheillan D; Rymen D; Rychtarova L; Hansikova H; Bury M; Dewulf JP; Caligiore F; Jaeken J; Cantagrel V; Van Schaftingen E; Matthijs G; Foulquier F; Bommer GT
    Cell; 2024 Jul; 187(14):3585-3601.e22. PubMed ID: 38821050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.